-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Jazz Pharmaceuticals plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Jazz Pharmaceuticals plc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$14.5M, a 69.2% increase year-over-year.
- Jazz Pharmaceuticals plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$66.6M, a 64.4% increase year-over-year.
- Jazz Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2023 was -$120M, a 24.4% increase from 2022.
- Jazz Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2022 was -$159M, a 173% decline from 2021.
- Jazz Pharmaceuticals plc annual Income Tax Expense (Benefit) for 2021 was $216M, a 545% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)